- November 17, 2023Source: Yale News
Faculty offer insight on the role of AI in radiology
- November 01, 2023
YSM alum Mandy Cohen takes the helm at the CDC
- October 27, 2023Source: Healthcare IT News
Yale New Haven radiologists boost CT scan reviews with AI
- October 09, 2023
CDC Director Talks About Building Trust, Addressing Health Disparities During Yale Visit
- November 16, 2022
Yale undergraduate team takes first place in national health policy competition
- November 23, 2021Source: Youtube
ASER 2021 Gold Medal Award Presentation, Dr. Michele Johnson
- September 04, 2020
Emergency Radiology Provides Overnight Care at Bridgeport Hospital
- April 15, 2020
Yale Radiologists Share COVID-19 Expertise At Home and Abroad
- July 22, 2019
Emergency Radiology Celebrates 20 Years
Emergency Radiology
General Information
P.O. Box 208042, CH 272B
New Haven, CT 06520-8042 Admin Assistant, Nel Rodríguez |
Phone:
|
203-785-2168
|
The goal of the Emergency/Trauma Imaging section is to provide high quality, timely, final reports to all ER patients requiring urgent radiological services The ER/Trauma Imaging section was one of the first programs in the country to staff on-site attending radiologists 24 hours a day, 7 days a week.
Schedule and Staffing
Since 1998 the ER/Trauma section has been providing seamless coverage to the York Street Campus, which serves as both a Level 1 Trauma Center and Level 1 Stroke Center. The ER/Trauma section has significantly expanded in 2019, and now provides 24/7/365 final reports for imaging studies across four of the Yale New Haven Health System Emergency Rooms (York Street Campus, St. Raphael’s Campus, Shoreline, and Milford). The section also provides overnight reads for inpatients at these locations and all patients at the West Haven VA Medical Center and Bridgeport Hospital. With this vast coverage, our ER/Trauma radiologists interpret over 200,000 studies annually. Quality care is obtained by multiple overlapping shifts throughout the day and night.
Our 12 full-time faculty members and 2 Leadership in Healthcare Fellows are core to the success of our section. In addition, there is opportunity for our Board Eligible and/or Certified Diagnostic Radiology fellows from our various sub-specialties to moonlight on evenings, weekends and holidays. This experience allows fellows from other sections to gain attending level experience. An active quality assurance process ensures appropriate oversight of generalists by our subspecialist radiologists to maintain uniformity of service with the highest level of subspecialty care to all patients.
Yale medical students form the backbone of our unique ER Radiology triage program. An active and healthy academic relationship also exists between ER radiology and various clinical services within Yale.
Research Direction
- Trauma imaging
- CT Scanners
- CT angiography
- Ramifications of obesity on diagnostic imaging
- The role of CT scans in redefining pediatric and adult anatomy
- Healthcare policy & Health economics
- Medicare and Medicaid finance
- Radiation risks and consent practices
- Cardiothoracic Imaging in the emergent setting
- Pulmonary embolism
- Artificial Intelligence
Yale ER/Trauma Imaging section radiologists are consistently published in national and international newspapers, magazines, and peer reviewed journal articles.
Education
The ER/Trauma imaging section sponsors two distinct fellowships.
The Healthcare Leadership in Radiology fellowship is a 2 year program jointly sponsored by Yale Department of Radiology and Yale School of Management (hyperlink). The fellow performs clinical duties at Yale New Haven Hospital while earning an MBA degree.
The ER/Trauma Radiology fellowship is a traditional 1 year program with focus on development of clinical skills.
Recent Publications
2024
- Abbreviated MRI in the evaluation of dizziness: report turnaround times and impact on length of stay compared to CT, CTA, and conventional MRI.Tu LH, Tegtmeyer K, de Oliveira Santo ID, Venkatesh AK, Forman HP, Mahajan A, Melnick ER. Emerg Radiol. 2024 Jul 22; 2024 Jul 22. PMID: 39034381.
- Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.Zinter MS, Dvorak CC, Mayday MY, Reyes G, Simon MR, Pearce EM, Kim H, Shaw PJ, Rowan CM, Auletta JJ, Martin PL, Godder K, Duncan CN, Lalefar NR, Kreml EM, Hume JR, Abdel-Azim H, Hurley C, Cuvelier GDE, Keating AK, Qayed M, Killinger JS, Fitzgerald JC, Hanna R, Mahadeo KM, Quigg TC, Satwani P, Castillo P, Gertz SJ, Moore TB, Hanisch B, Abdel-Mageed A, Phelan R, Davis DB, Hudspeth MP, Yanik GA, Pulsipher MA, Sulaiman I, Segal LN, Versluys BA, Lindemans CA, Boelens JJ, DeRisi JL. Nat Med. 2024 Jul; 2024 May 23. PMID: 38783139.
- Response to letter.Amin KS, Forman HP, Davis MA. Clin Imaging. 2024 Jul; 2024 May 7. PMID: 38735100.
- Lower Urinary Tract Symptoms in US Women: Contemporary Prevalence Estimates from the RISE FOR HEALTH Study.Sutcliffe S, Falke C, Fok CS, Griffith JW, Harlow BL, Kenton KA, Lewis CE, Low LK, Lowder JL, Lukacz ES, Markland AD, McGwin G, Meister MR, Mueller ER, Newman DK, Pakpahan R, Rickey LM, Rockwood T, Simon MA, Smith AR, Rudser KD, Smith AL. J Urol. 2024 Jul; 2024 May 4. PMID: 38703067.
- Phosphorylation of the nuclear poly(A) binding protein (PABPN1) during mitosis protects mRNA from hyperadenylation and maintains transcriptome dynamics.Gordon JM, Phizicky DV, Schärfen L, Brown CL, Arias Escayola D, Kanyo J, Lam TT, Simon MD, Neugebauer KM. Nucleic Acids Res. 2024 Jun 29; 2024 Jun 29. PMID: 38943343.
- The Brain Tumor Segmentation - Metastases (BraTS-METS) Challenge 2023: Brain Metastasis Segmentation on Pre-treatment MRI.Moawad AW, Janas A, Baid U, Ramakrishnan D, Saluja R, Ashraf N, Jekel L, Amiruddin R, Adewole M, Albrecht J, Anazodo U, Aneja S, Anwar SM, Bergquist T, Calabrese E, Chiang V, Chung V, Conte GMM, Dako F, Eddy J, Ezhov I, Familiar A, Farahani K, Iglesias JE, Jiang Z, Johanson E, Kazerooni AF, Kofler F, Krantchev K, LaBella D, Van Leemput K, Li HB, Linguraru MG, Link KE, Liu X, Maleki N, Meier Z, Menze BH, Moy H, Osenberg K, Piraud M, Reitman Z, Shinohara RT, Tahon NH, Nada A, Velichko YS, Wang C, Wiestler B, Wiggins W, Shafique U, Willms K, Avesta A, Bousabarah K, Chakrabarty S, Gennaro N, Holler W, Kaur M, LaMontagne P, Lin M, Lost J, Marcus DS, Maresca R, Merkaj S, Nada A, Pedersen GC, von Reppert M, Sotiras A, Teytelboym O, Tillmans N, Westerhoff M, Youssef A, Godfrey D, Floyd S, Rauschecker A, Villanueva-Meyer J, Pflüger I, Cho J, Bendszus M, Brugnara G, Cramer J, Perez-Carillo GJG, Johnson DR, Kam A, Kwan BYM, Lai L, Lall NU, Memon F, Patro SN, Petrovic B, So TY, Thompson G, Wu L, Schrickel EB, Bansal A, Barkhof F, Besada C, Chu S, Druzgal J, Dusoi A, Farage L, Feltrin F, Fong A, Fung SH, Gray RI, Ikuta I, Iv M, Postma AA, Mahajan A, Joyner D, Krumpelman C, Letourneau-Guillon L, Lincoln CM, Maros ME, Miller E, Morón F, Nimchinsky EA, Ozsarlak O, Patel U, Rohatgi S, Saha A, Sayah A, Schwartz ED, Shih R, Shiroishi MS, Small JE, Tanwar M, Valerie J, Weinberg BD, White ML, Young R, Zohrabian VM, Azizova A, Brüßeler MMT, Fehringer P, Ghonim M, Ghonim M, Gkampenis A, Okar A, Pasquini L, Sharifi Y, Singh G, Sollmann N, Soumala T, Taherzadeh M, Yordanov N, Vollmuth P, Foltyn-Dumitru M, Malhotra A, Abayazeed AH, Dellepiane F, Lohmann P, Pérez-García VM, Elhalawani H, Al-Rubaiey S, Armindo RD, Ashraf K, Asla MM, Badawy M, Bisschop J, Lomer NB, Bukatz J, Chen J, Cimflova P, Corr F, Crawley A, Deptula L, Elakhdar T, Shawali IH, Faghani S, Frick A, Gulati V, Haider MA, Hierro F, Dahl RH, Jacobs SM, Hsieh KJ, Kandemirli SG, Kersting K, Kida L, Kollia S, Koukoulithras I, Li X, Abouelatta A, Mansour A, Maria-Zamfirescu RC, Marsiglia M, Mateo-Camacho YS, McArthur M, McDonnell O, McHugh M, Moassefi M, Morsi SM, Muntenu A, Nandolia KK, Naqvi SR, Nikanpour Y, Alnoury M, Nouh AMA, Pappafava F, Patel MD, Petrucci S, Rawie E, Raymond S, Roohani B, Sabouhi S, Sanchez-Garcia LM, Shaked Z, Suthar PP, Altes T, Isufi E, Dhermesh Y, Gass J, Thacker J, Tarabishy AR, Turner B, Vacca S, Vilanilam GK, Warren D, Weiss D, Willms K, Worede F, Yousry S, Lerebo W, Aristizabal A, Karargyris A, Kassem H, Pati S, Sheller M, Bakas S, Rudie JD, Aboian M. ArXiv. 2024 Jun 17; 2024 Jun 17. PMID: 37396600.
- Editorial Comment: Radiology Practice Consolidation Is on the Rise-But Bigger Is Not Always Better.Mezrich JL. AJR Am J Roentgenol. 2024 Jun 12; 2024 Jun 12. PMID: 38864703.
- Pre-diagnostic plasma inflammatory proteins and risk of hepatocellular carcinoma in three population-based cohort studies from the United States and the United Kingdom.Zhao L, Zhang X, Birmann BM, Danford CJ, Lai M, Simon TG, Chan AT, Giovannucci EL, Ngo L, Libermann TA, Zhang X. Int J Cancer. 2024 Jun 11; 2024 Jun 11. PMID: 38861327.
- Predictors of Outcomes in Cerebellar Stroke: A Retrospective Cohort Study From the National Inpatient Sample Data.Prasad A, Nookala V, Machchar R, Simon JR, Nakka LA, Vanamala T, Mehta S, Ramesh A, Schilling AL, Hollenbeak CS, Cheriyath P. Cureus. 2024 Jun; 2024 Jun 9. PMID: 38989368.
- Dengue NS1 antibodies are associated with clearance of viral NS1.Premazzi Papa M, Mendoza-Torres E, Sun P, Encinales L, Goulet J, Defang G, Vihasi J, Cheng Y, Suchowiecki K, Rosales W, Amdur R, Porras-Ramirez A, Rico-Mendoza A, Herrera Gomez C, Nicholes S, Zuluaga I, Halstead L, Halstead S, Simon G, Porter K, Lynch RM, Chang AY. J Infect Dis. 2024 Jun 6; 2024 Jun 6. PMID: 38842497.
- Establishing robust governance of clinical artificial intelligence software - Why radiologists should lead.Cavallo JJ, Davis MA. Clin Imaging. 2024 Jun; 2024 Apr 20. PMID: 38678765.
- Socioecological factors associated with multiple nicotine product use among U.S. youth: Findings from the population assessment of tobacco and health (PATH) study 2013-2018.Simon P, Stefanovics E, Ying S, Gueorguieva R, Krishnan-Sarin S, Buta E. Prev Med. 2024 Jun; 2024 Apr 13. PMID: 38615947.
- Guideline ambivalence may contribute to conservative IV contrast premedication policies.Malhotra A, Mezrich J. J Am Coll Radiol. 2024 Jun; 2023 Nov 11. PMID: 37956884.
- Turn Your Vision into Reality-AI-Powered Pre-operative Outcome Simulation in Rhinoplasty Surgery.Knoedler S, Alfertshofer M, Simon S, Panayi AC, Saadoun R, Palackic A, Falkner F, Hundeshagen G, Kauke-Navarro M, Vollbach FH, Bigdeli AK, Knoedler L. Aesthetic Plast Surg. 2024 May 22; 2024 May 22. PMID: 38777929.
- Behavioral Precursors of Nicotine Product Use Trajectories Among Youth.Buta E, Gueorguieva R, Simon P, Garrison KA. Am J Prev Med. 2024 May 21; 2024 May 21. PMID: 38782105.
- Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statement.Hohenschurz-Schmidt D, Cherkin D, Rice ASC, Dworkin RH, Turk DC, McDermott MP, Bair MJ, DeBar LL, Edwards RR, Evans SR, Farrar JT, Kerns RD, Rowbotham MC, Wasan AD, Cowan P, Ferguson M, Freeman R, Gewandter JS, Gilron I, Grol-Prokopczyk H, Iyengar S, Kamp C, Karp BI, Kleykamp BA, Loeser JD, Mackey S, Malamut R, McNicol E, Patel KV, Schmader K, Simon L, Steiner DJ, Veasley C, Vollert J. Pain. 2024 May 3; 2024 May 3. PMID: 38723171.
- Pre-diagnostic plasma proteomics profile for hepatocellular carcinoma.Zhang X, Zhao L, Ngo LH, Dillon ST, Gu X, Lai M, Simon TG, Chan AT, Giovannucci EL, Libermann TA, Zhang X. J Natl Cancer Inst. 2024 May 1; 2024 May 1. PMID: 38688524.
- Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL. Lancet Oncol. 2024 May; 2024 Mar 29. PMID: 38561010.
- Even with ChatGPT, race matters.Amin KS, Forman HP, Davis MA. Clin Imaging. 2024 May; 2024 Mar 2. PMID: 38552383.
- Caveat Emptor: Medicolegal Issues May Arise From the Opaque and Unpredictable Nature of Current Large Language Models Used in Diagnostic Imaging.Beheshtian E, Siegel EL, Mezrich JL. Acad Radiol. 2024 May; 2024 Jan 11. PMID: 38216415.